DK0799223T3 - Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler - Google Patents

Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler

Info

Publication number
DK0799223T3
DK0799223T3 DK95942704T DK95942704T DK0799223T3 DK 0799223 T3 DK0799223 T3 DK 0799223T3 DK 95942704 T DK95942704 T DK 95942704T DK 95942704 T DK95942704 T DK 95942704T DK 0799223 T3 DK0799223 T3 DK 0799223T3
Authority
DK
Denmark
Prior art keywords
piperidinedacetic
acid derivatives
antagonist agents
fibrinogen antagonist
fibrinogen
Prior art date
Application number
DK95942704T
Other languages
English (en)
Inventor
David George Allen
Colin David Eldred
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9426231.8A external-priority patent/GB9426231D0/en
Priority claimed from GBGB9503133.2A external-priority patent/GB9503133D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0799223T3 publication Critical patent/DK0799223T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95942704T 1994-12-23 1995-12-21 Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler DK0799223T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9426231.8A GB9426231D0 (en) 1994-12-23 1994-12-23 Chemical compounds
GBGB9503133.2A GB9503133D0 (en) 1995-02-17 1995-02-17 Chemical compounds
PCT/EP1995/005043 WO1996020192A1 (en) 1994-12-23 1995-12-21 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent

Publications (1)

Publication Number Publication Date
DK0799223T3 true DK0799223T3 (da) 1999-12-27

Family

ID=26306268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95942704T DK0799223T3 (da) 1994-12-23 1995-12-21 Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler

Country Status (21)

Country Link
US (1) US5861414A (da)
EP (1) EP0799223B1 (da)
JP (1) JPH10511375A (da)
CN (1) CN1175254A (da)
AP (1) AP9701010A0 (da)
AR (1) AR002260A1 (da)
AT (1) ATE181071T1 (da)
AU (1) AU704496B2 (da)
CO (1) CO4700291A1 (da)
DE (1) DE69510228T2 (da)
DK (1) DK0799223T3 (da)
ES (1) ES2132761T3 (da)
FI (1) FI972684A0 (da)
GR (1) GR3031027T3 (da)
IL (1) IL116480A0 (da)
NO (1) NO972887L (da)
NZ (1) NZ298400A (da)
PE (1) PE63696A1 (da)
SI (1) SI0799223T1 (da)
WO (1) WO1996020192A1 (da)
ZA (1) ZA951822B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760028A (en) * 1995-12-22 1998-06-02 The Dupont Merck Pharmaceutical Company Integrin receptor antagonists
GB9613096D0 (en) * 1996-06-21 1996-08-28 Glaxo Group Ltd Medicaments
EP0934311B1 (de) 1996-10-14 2009-05-13 Bayer HealthCare AG Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen
US6214834B1 (en) 1997-03-28 2001-04-10 Dupont Pharmaceuticals Company Integrin inhibitor prodrugs
TWI262914B (en) * 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
US7141581B2 (en) * 1999-07-02 2006-11-28 Agouron Pharmaceuticals, Inc. Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
KR20030062442A (ko) * 2000-12-22 2003-07-25 와이어쓰 5-하이드록시트립타민-6-리간드로서의 헤테로사이클인다졸및 아자인다졸 화합물
US7008953B2 (en) 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
TW200616967A (en) * 2004-06-24 2006-06-01 Smithkline Beecham Corp Novel indazole carboxamides and their use
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681382A (en) * 1969-02-07 1972-08-01 Ciba Geigy Corp 3-aminoindazoles
AU2915892A (en) * 1991-11-14 1993-06-15 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
JPH05255308A (ja) * 1992-03-11 1993-10-05 Ajinomoto Co Inc ピペリジン誘導体
JP3194777B2 (ja) * 1992-03-13 2001-08-06 学校法人東京薬科大学 立体選択的ｄ−リボフラノシル化法
JPH06234633A (ja) * 1993-02-10 1994-08-23 Ajinomoto Co Inc アミン誘導体およびこれを含有する抗血小板剤

Also Published As

Publication number Publication date
NO972887D0 (no) 1997-06-20
ZA951822B (en) 1996-09-26
IL116480A0 (en) 1996-03-31
AP9701010A0 (en) 1997-07-31
AU704496B2 (en) 1999-04-22
EP0799223B1 (en) 1999-06-09
US5861414A (en) 1999-01-19
CO4700291A1 (es) 1998-12-29
WO1996020192A1 (en) 1996-07-04
GR3031027T3 (en) 1999-12-31
CN1175254A (zh) 1998-03-04
FI972684A (fi) 1997-06-19
SI0799223T1 (en) 1999-10-31
PE63696A1 (es) 1997-01-11
AU4387896A (en) 1996-07-19
DE69510228T2 (de) 1999-11-04
AR002260A1 (es) 1998-03-11
JPH10511375A (ja) 1998-11-04
NZ298400A (en) 1999-10-28
NO972887L (no) 1997-08-20
DE69510228D1 (de) 1999-07-15
ES2132761T3 (es) 1999-08-16
EP0799223A1 (en) 1997-10-08
ATE181071T1 (de) 1999-06-15
FI972684A0 (fi) 1997-06-19

Similar Documents

Publication Publication Date Title
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
DK0560268T3 (da) Substituerede pipecolinsyrederivater som HIV-proteasehæmmere
DK0569013T3 (da) Quinolinforbindelser som angiotensin II antagonister
NO983603D0 (no) Substituerte sulfonsyre N-£(aminoiminometyl)-fenylalkyl|-azaheterocyklamid-forbindelser
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
FI951009A0 (fi) Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä
DK0799223T3 (da) Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
NO982651D0 (no) 3-Azetidinylalkylpiperidiner eller -pyrrolidiner som takykininantagonister
NO971789D0 (no) Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler
NO991994L (no) Substituerte 4-bifenyl-4-hydroksysm°rsyrederivater som matriksmetalloproteaseinhibitorer
DE69801941T2 (de) Kautschukzusammensetzungen welche o-Salicylsalicylicsäure enthalten
DK1086097T3 (da) Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO20006227L (no) Tetrahydroquiolinderivater som glycin antagonister
NO961333D0 (no) Nye pyrazolderivater som angiotensin-II-antagonister
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO950684D0 (no) Nye imidazopyridinderivater som angiotensinII-antagonister
NO995782L (no) Kvarternaere ammoniumforbindelser som tachykinin-antagonister
NO993812L (no) (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler
NO20001751D0 (no) Nye forbindelser til bruk som neuroprotektive midler
FI943359A0 (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
NO972905D0 (no) Tienoksasinon-derivater anvendelige som antivirusmidler
DK0660715T3 (da) Carbostyrilderivater som antiarytmiske midler